The Motley Fool

Tempted by the Provident Financial share price? I think these small-cap stocks are far better buys

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Heart-shaped balloon
Image source: Getty Images.

The attempted takeover of doorstep lender Provider Financial (LSE: PFG) by less-well-known rival Non-Standard Finance — as summarised here by my Foolish colleague Rupert Hargreaves and supported by fund manager Neil Woodford — was firmly rebuffed by the former’s management team again in last week’s full-year results. 

According to CEO Malcolm Le May and co, the £1.3bn offer undervalues the company and its prospects as well as presenting “significant operational and execution risks given NSF’s track record of value destruction“. Ouch. 

5 Stocks For Trying To Build Wealth After 50

Markets around the world are reeling from the coronavirus pandemic… and with so many great companies trading at what look to be ‘discount-bin’ prices, now could be the time for savvy investors to snap up some potential bargains.

But whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times.

Fortunately, The Motley Fool UK analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global upheaval…

We’re sharing the names in a special FREE investing report that you can download today. And if you’re 50 or over, we believe these stocks could be a great fit for any well-diversified portfolio.

Click here to claim your free copy now!

Instead, shareholders are being asked to put their faith in Provident’s management team and their strategy to return the business to growth.

Based on last week’s numbers, they do appear to be making at least some progress. The mid-cap reported a statutory pre-tax profit of £90.7m for 2018 compared to a £147.9m loss the year before.

Shares understandably reacted well to the news, although they’re still worth 75% less than the 2,300p-a-pop valuation hit back in April 2017. 

Quite what happens next is anyone’s guess, particularly as the Competition and Markets Authority (CMA) has confirmed that it will investigate Non-Standard Finance’s bid and Provident has refused to comment on whether it is in talks with other companies on a possible merger.

Personally, I can do without the hassle of wondering how this increasingly hostile state of affairs will resolve itself. Investing is hard at the best of times and attempting to profit from such uncertainty (as opposed to the more general ‘be greedy when others are fearful’ maxim) is fraught with risk. 

Moreover, the dividends aren’t really worth the bother. A 10p total cash return for the last financial year gives a trailing yield of just 1.7% — far less than you can get elsewhere in the market

All things considered, I certainly won’t be joining the queue for Provident’s stock.


Right now, I still favour a different set of alternative ‘financial’ stocks, namely pawnbrokers Ramsdens Holdings (LSE: RCX) and H&T Group (LSE: HAT).

Last week, the latter released another encouraging set of full-year numbers, which included a 13.4% rise in pre-tax profit to £13.5m and, interestingly, a 37.6% rise in its net loan book from £14.9m to £20.5m.

For its part, Ramsdens recently revealed that it had bought 18 stores trading as The Money Shop for a total consideration of £1.5m. Management expects these will make “a small contribution” to pre-tax profit in FY 2020 and “approximately £0.6m” the following year. More deals like this are expected. 

To be clear, these are not glamour stocks whose share prices will rocket. They are, however, well run, diversified businesses (both also offer foreign exchange currency services and are involved in gold purchasing and jewellery retail) and should do well if the economy takes a turn for the worse in the next few years.

Another positive is that both still trade on the same reasonable valuation of around 11 times forecast earnings. Dividend yields are pretty much identical at 4.1% and are covered over twice by expected profits at each company. 

That said, I’m perfectly happy to stick with only owning stock in Ramsdens for now. Returns on capital and operating margins are higher at H&T’s smaller rival and it also had net cash of £12.4m at the half-year point back at the end of November. Expect an end-of-year trading update in early April.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Paul Summers owns shares in Ramsdens Holdings. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.